Erin L. Kirk
- Molecular Biology
- Immunology top 5%
- Cancer Research top 5%
- Oncology top 10%
- Epidemiology
- Co-authors
- Melissa A. TroesterJeffery C. RathmellAlex J. FreemermanAmy R. JohnsonPankuri Goraksha-HicksLiza MakowskiAndrew N. MacintyreJ. Justin Milner
- Topics
- Breast Cancer Treatment Studies (16 papers)Cancer Risks and Factors (8 papers)Cancer Genomics and Diagnostics (7 papers)
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- United StatesSouth AfricaChina
In The Last Decade
Erin L. Kirk
36 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 590
- Immunology 483
- Cancer Research 454
- Oncology 361
- Epidemiology 210
Countries citing papers authored by Erin L. Kirk
This map shows the geographic impact of Erin L. Kirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin L. Kirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin L. Kirk more than expected).
Fields of papers citing papers by Erin L. Kirk
This network shows the impact of papers produced by Erin L. Kirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin L. Kirk. The network helps show where Erin L. Kirk may publish in the future.
Co-authorship network of co-authors of Erin L. Kirk
This figure shows the co-authorship network connecting the top 25 collaborators of Erin L. Kirk. A scholar is included among the top collaborators of Erin L. Kirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin L. Kirk. Erin L. Kirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 9 | |
| 6 | 8 | |
| 7 | 33 | |
| 8 | 6 | |
| 9 | 9 | |
| 10 | 13 | |
| 11 | 1 | |
| 12 | 10 | |
| 13 | 3 | |
| 14 | 6 | |
| 15 | 2 | |
| 16 | 8 | |
| 17 | 41 | |
| 18 | 24 | |
| 19 | 15 | |
| 20 | 138 |
About Erin L. Kirk
Erin L. Kirk is a scholar working on Cancer Research, Oncology and Genetics, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (16 papers), Cancer Risks and Factors (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Cancer Research (454 citations), Immunology (483 citations) and Oncology (361 citations). Erin L. Kirk has collaborated with scholars based in United States, South Africa and China. Frequent co-authors include Melissa A. Troester, Jeffery C. Rathmell, Alex J. Freemerman, Amy R. Johnson, Pankuri Goraksha-Hicks, Liza Makowski, Andrew N. Macintyre, J. Justin Milner, Charles M. Perou and Xuezheng Sun. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.